Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-06-02

Clinical Trial Update: A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of dapivirine vaginal microbicide gel (TMC120) is completed. The trial was sponsored by the International Partnership for Microbic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapivirine vaginal gel (TMC120) (dapivirine)

Snippet

Sponsor: International Partnership for Microbicides, Inc. | Conditions: HIV Infections | Phase 1 | Status: COMPLETED